Your year-round gateway to the global biopharma partnering community—access exclusive insights, strategic connections, and industry expertise from Europe's largest partnering event.
Expand your BIO-Europe partnering experience beyond the event with curated speaker interviews, session highlights, and strategic content that keeps you connected to potential partners across the biotechnology value chain.
Meet our Open Plenary Speakers
Jeremy Levin, CEO and Chairman of Ovid Therapeutics
Dr. Levin serves as Chairman/CEO of Ovid Therapeutics and Chairman of Opthea, following leadership roles at Teva Pharmaceuticals, Bristol-Myers Squibb, and Novartis. An Oxford and Cambridge graduate with medical degrees, he's a recognized industry pioneer and recipient of the 2023 Scrip Lifetime Achievement Award. Dr. Levin authored "Biotechnology in the Time of COVID-19" and serves as Emeritus Chairman on BIO's Board.
David Loew, CEO at IPSEN
David Loew has served as the Chief Executive Officer of Ipsen since July 1, 2020. A veteran pharmaceutical executive with nearly three decades of industry experience, David brings extensive leadership across multiple therapeutic areas including oncology, neuroscience, cardio-metabolism, and consumer healthcare.
Key topics being explored at BIO-Europe
What are the main content themes typically covered at BIO-Europe?
BIO-Europe explores vital industry topics including artificial intelligence applications in drug development, pharmaceutical innovation, preventive medicine approaches, and big data utilization in life sciences. The program typically features tracks covering Business of Biotech, Therapeutic Insights, and Ecosystem Innovation.
How does BIO-Europe support emerging biotech companies?
Beyond networking opportunities, the conference offers specialized content for early-stage companies, including the Startup Spotlight pitch competition, dedicated sessions on scaling biotech businesses, and insights on navigating partnerships with larger pharmaceutical companies.
How does the partnering system enhance deal-making opportunities?
The partneringONE® system allows participants to identify potential partners based on specific criteria, schedule one-to-one meetings, and manage their partnering calendar efficiently. This targeted approach helps maximize productive connections during the event.
What insights will I gain about biotech investment trends?
Sessions cover current investment landscapes, emerging funding models, valuation trends, and strategies for attracting capital in challenging markets. Perspectives from venture capitalists, private equity firms, and corporate investors provide a comprehensive view of the funding ecosystem.
What networking opportunities are available beyond one-to-one meetings?
BIO-Europe offers various networking events including a stylish opening reception at Vienna City Hall and a grand evening event at the Hofburg Palace. These social gatherings complement the formal partnering meetings and provide additional opportunities for connection in Vienna's historic settings.
21Questions with Anna Chrisman
This exclusive interview takes you behind the scenes with our Life Science president at BIO-Europe Spring in Milan! Through a series of thoughtful questions, discover Anna's professional insights and personal perspectives on the biotech industry's premier partnering event.